JP2014521313A5 - - Google Patents

Download PDF

Info

Publication number
JP2014521313A5
JP2014521313A5 JP2014519454A JP2014519454A JP2014521313A5 JP 2014521313 A5 JP2014521313 A5 JP 2014521313A5 JP 2014519454 A JP2014519454 A JP 2014519454A JP 2014519454 A JP2014519454 A JP 2014519454A JP 2014521313 A5 JP2014521313 A5 JP 2014521313A5
Authority
JP
Japan
Prior art keywords
seq
antibody
antigen
cells
binding fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014519454A
Other languages
English (en)
Japanese (ja)
Other versions
JP6431370B2 (ja
JP2014521313A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/002945 external-priority patent/WO2013007388A1/en
Publication of JP2014521313A publication Critical patent/JP2014521313A/ja
Publication of JP2014521313A5 publication Critical patent/JP2014521313A5/ja
Application granted granted Critical
Publication of JP6431370B2 publication Critical patent/JP6431370B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014519454A 2011-07-13 2012-07-13 組換えDsbCを発現する細菌宿主系統 Active JP6431370B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11173880.3 2011-07-13
EP11173880 2011-07-13
PCT/EP2012/002945 WO2013007388A1 (en) 2011-07-13 2012-07-13 Bacterial host strain expressing recombinant dsbc

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017209932A Division JP2018019719A (ja) 2011-07-13 2017-10-31 組換えDsbCを発現する細菌宿主系統

Publications (3)

Publication Number Publication Date
JP2014521313A JP2014521313A (ja) 2014-08-28
JP2014521313A5 true JP2014521313A5 (enExample) 2017-03-09
JP6431370B2 JP6431370B2 (ja) 2018-11-28

Family

ID=46545736

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014519454A Active JP6431370B2 (ja) 2011-07-13 2012-07-13 組換えDsbCを発現する細菌宿主系統
JP2017209932A Pending JP2018019719A (ja) 2011-07-13 2017-10-31 組換えDsbCを発現する細菌宿主系統
JP2019200029A Active JP7062626B2 (ja) 2011-07-13 2019-11-01 組換えDsbCを発現する細菌宿主系統

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2017209932A Pending JP2018019719A (ja) 2011-07-13 2017-10-31 組換えDsbCを発現する細菌宿主系統
JP2019200029A Active JP7062626B2 (ja) 2011-07-13 2019-11-01 組換えDsbCを発現する細菌宿主系統

Country Status (27)

Country Link
US (2) US9725516B2 (enExample)
EP (2) EP3339325A1 (enExample)
JP (3) JP6431370B2 (enExample)
KR (1) KR102023786B1 (enExample)
CN (1) CN103649124B (enExample)
AU (1) AU2012283388B2 (enExample)
BR (1) BR112013032871B1 (enExample)
CA (1) CA2841824C (enExample)
CY (1) CY1119985T1 (enExample)
DK (1) DK2731973T3 (enExample)
EA (1) EA031449B1 (enExample)
ES (1) ES2659155T3 (enExample)
HR (1) HRP20180226T1 (enExample)
HU (1) HUE035674T2 (enExample)
IL (1) IL229947B (enExample)
IN (1) IN2014DN00202A (enExample)
LT (1) LT2731973T (enExample)
ME (1) ME02957B (enExample)
MX (1) MX348738B (enExample)
NO (1) NO2731973T3 (enExample)
PL (1) PL2731973T3 (enExample)
PT (1) PT2731973T (enExample)
RS (1) RS56926B1 (enExample)
SG (1) SG10201807560XA (enExample)
SI (1) SI2731973T1 (enExample)
SM (1) SMT201800068T1 (enExample)
WO (1) WO2013007388A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2125894B1 (en) * 2007-03-22 2018-12-19 Biogen MA Inc. Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof
IN2012DN02401A (enExample) 2009-09-24 2015-08-21 Ucb Pharma Sa
GB201000591D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000590D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
PL2731973T3 (pl) * 2011-07-13 2018-04-30 Ucb Biopharma Sprl Bakteryjny szczep gospodarz wykazujący ekspresję dsbc
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product
GB201223276D0 (en) * 2012-12-21 2013-02-06 Ucb Pharma Sa Antibodies and methods of producing same
SG11201704836XA (en) 2014-12-22 2017-07-28 Ucb Biopharma Sprl Protein manufacture
KR101810778B1 (ko) * 2015-06-23 2017-12-20 서울대학교산학협력단 Cd154 결합 폴리펩타이드 및 그 용도
WO2017132298A1 (en) 2016-01-27 2017-08-03 Medimmune, Llc Methods for preparing antibodies with a defined glycosylation pattern
EP3774926A1 (en) 2018-04-05 2021-02-17 Bio-Rad ABD Serotec GmbH Display systems for proteins of interest
EP3877407B1 (en) * 2018-11-05 2026-03-11 F. Hoffmann-La Roche AG Methods of producing two chain proteins in prokaryotic host cells
CN109371049A (zh) * 2018-11-14 2019-02-22 天津大学 分子伴侣在促进单克隆抗体的形成和/或提高单克隆抗体的表达量中的应用
WO2020188350A1 (en) 2019-03-18 2020-09-24 Bio-Rad Abd Serotec Gmbh Protection of spytag-containing periplasmic fusion proteins from protease tsp and ompt degradation
EP4010500B1 (de) * 2019-08-05 2025-02-19 Wacker Chemie AG Bakterienstamm zur freisetzung eines rekombinanten proteins in einem fermentationsverfahren

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
GB8907617D0 (en) 1989-04-05 1989-05-17 Celltech Ltd Drug delivery system
US5508192A (en) 1990-11-09 1996-04-16 Board Of Regents, The University Of Texas System Bacterial host strains for producing proteolytically sensitive polypeptides
US5264365A (en) 1990-11-09 1993-11-23 Board Of Regents, The University Of Texas System Protease-deficient bacterial strains for production of proteolytically sensitive polypeptides
GB9112536D0 (en) 1991-06-11 1991-07-31 Celltech Ltd Chemical compounds
US5474771A (en) 1991-11-15 1995-12-12 The Trustees Of Columbia University In The City Of New York Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same
AU4118393A (en) 1992-04-28 1993-11-29 Regents Of The University Of Michigan, The Human crabp-I and crabp-II
GB9215540D0 (en) 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
US5304472A (en) 1992-11-20 1994-04-19 Genentech, Inc. Method of controlling polypeptide production in bacterial cells
US5639635A (en) 1994-11-03 1997-06-17 Genentech, Inc. Process for bacterial production of polypeptides
US6027888A (en) 1996-04-05 2000-02-22 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide-bond containing eukaryotic proteins in bacterial cells
GB9625640D0 (en) 1996-12-10 1997-01-29 Celltech Therapeutics Ltd Biological products
US6083715A (en) 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
JP2000083670A (ja) 1998-09-09 2000-03-28 Hsp Kenkyusho:Kk DsbA/DsbB/DsbC/DsbD発現プラスミド
AU767670B2 (en) 1999-06-29 2003-11-20 Siga Technologies, Inc. DEGP periplasmic protease a new anti-infective target and an invitro assay for DEGP protease function
GB0006398D0 (en) 2000-03-16 2000-05-03 Novartis Ag Organic compounds
GB0013810D0 (en) 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
AU8867501A (en) 2000-09-01 2002-03-13 Biogen Inc Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
AU2001287040A1 (en) 2000-09-01 2002-03-13 Biogen, Inc. Methods of designing and producing novel compounds having improved binding affinity for cd154 or other trimeric proteins
US7041479B2 (en) 2000-09-06 2006-05-09 The Board Of Trustess Of The Leland Stanford Junior University Enhanced in vitro synthesis of active proteins containing disulfide bonds
MXPA03005273A (es) * 2000-12-14 2003-09-25 Genentech Inc Anticuerpos producidos procarioticamente y sus usos.
CA2430249A1 (en) 2000-12-14 2002-06-20 Genentech, Inc. Bacterial host strains
TWI334439B (en) 2001-08-01 2010-12-11 Centocor Inc Anti-tnf antibodies, compositions, methods and uses
EP1427744B1 (en) * 2001-08-27 2007-12-26 Genentech, Inc. A system for antibody expression and assembly
GB0124317D0 (en) 2001-10-10 2001-11-28 Celltech R&D Ltd Biological products
IL161988A0 (en) 2001-11-16 2005-11-20 Corporation Idec Pharmaceutica Polycistronic expression of antibodies
GB0129105D0 (en) * 2001-12-05 2002-01-23 Celltech R&D Ltd Expression control using variable intergenic sequences
EP1517921B1 (en) 2002-06-28 2006-06-07 Domantis Limited Dual specific ligands with increased serum half-life
AU2003287345A1 (en) 2002-10-31 2004-06-07 Genentech, Inc. Methods and compositions for increasing antibody production
JP4603894B2 (ja) 2002-12-03 2010-12-22 ユセベ ファルマ ソシエテ アノニム 抗体産生細胞を同定するためのアッセイ
GB0303337D0 (en) 2003-02-13 2003-03-19 Celltech R&D Ltd Biological products
KR20120090094A (ko) 2003-06-13 2012-08-16 바이오겐 아이덱 엠에이 인코포레이티드 아글리코실 항-cd154(cd40 리간드) 항체 및 이의 용도
SI1639011T1 (sl) 2003-06-30 2009-04-30 Domantis Ltd Pegilirana protitelesa z enojno domeno (dAb)
GB0315450D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
GB0315457D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
NZ580688A (en) 2003-07-26 2012-03-30 Biogen Idec Inc Method of designing altered antibodies having improved antigen-binding affinity
EP2399936A3 (en) 2004-07-26 2012-02-22 Biogen Idec MA Inc. Anti-CD154 antibodies
AU2005282700A1 (en) * 2004-09-02 2006-03-16 Genentech, Inc. Heteromultimeric molecules
US7563443B2 (en) 2004-09-17 2009-07-21 Domantis Limited Monovalent anti-CD40L antibody polypeptides and compositions thereof
GB0425534D0 (en) 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
GB0520169D0 (en) 2005-10-04 2005-11-09 Celltech R&D Ltd Biological products
EP2125894B1 (en) 2007-03-22 2018-12-19 Biogen MA Inc. Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof
JP5592792B2 (ja) 2007-09-26 2014-09-17 ユセベ ファルマ ソシエテ アノニム 二重特異性抗体の融合体
US7662587B1 (en) 2009-03-05 2010-02-16 E. I. Du Pont De Nemours And Company Gene knockout mutations that increase peptide production
IN2012DN02401A (enExample) 2009-09-24 2015-08-21 Ucb Pharma Sa
US8470552B2 (en) 2009-10-12 2013-06-25 Keck Graduate Institute Strategy to reduce lactic acid production and control PH in animal cell culture
CN105274170A (zh) 2009-11-05 2016-01-27 弗·哈夫曼-拉罗切有限公司 分泌异源多肽的方法和组合物
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000590D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000591D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000588D0 (en) * 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201001791D0 (en) 2010-02-03 2010-03-24 Ucb Pharma Sa Process for obtaining antibodies
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
EP2546267A1 (en) 2011-07-13 2013-01-16 UCB Pharma S.A. Bacterial host strain expressing recombinant DsbC
PL2731973T3 (pl) 2011-07-13 2018-04-30 Ucb Biopharma Sprl Bakteryjny szczep gospodarz wykazujący ekspresję dsbc
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product

Similar Documents

Publication Publication Date Title
JP2014521313A5 (enExample)
Silva et al. Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses
JP2021020905A5 (enExample)
TWI713942B (zh) 與集落刺激因子1受體(csf1r)結合之抗體類
HRP20180226T1 (hr) Bakterijski soj domaćina koji eksprimira rekombinantnu dsbc
JP2018502572A5 (enExample)
JP5901679B2 (ja) 可溶性ポリペプチドの単離方法
JP2005120106A5 (enExample)
KR101796689B1 (ko) 안정화된 면역글로불린가변도메인 선별방법 및 선별된 도메인의 응용
JP2010273685A5 (enExample)
JP2018506298A (ja) アゴニスト性tnf受容体結合物質
JP2020500510A5 (enExample)
JP2011526480A5 (enExample)
JP2008301822A5 (enExample)
AU2007254004A1 (en) Engineered antibody-stress protein fusions
JP2009535021A5 (enExample)
JP2009511000A5 (enExample)
KR20180077144A (ko) 신규 항체 라이브러리 제조방법 및 이로부터 제조된 라이브러리
WO2022061594A1 (zh) 新型冠状病毒(sars-cov-2)刺突蛋白结合分子及其应用
JP2012524524A5 (enExample)
CN106928363B (zh) 一种FAP纳米抗体Nb12
JP2011523849A5 (enExample)
CN110964110A (zh) 抗EGFR人源化的单域抗体、Fc融合蛋白、重链Fab蛋白及其应用
JP2010279373A5 (enExample)
JP2008507253A5 (enExample)